References
- Kim RH, Bold RJ, Kung HJ. ADI, autophagy and apoptosis: metabolic stress as a therapeutic option for prostate cancer. Autophagy5, 567–568 (2009).
- Yang JC, Ok JH, Busby JE, Borowsky AD, Kung HJ, Evans CP. Aberrant activation of androgen receptor in a new neuropeptide-autocrine model of androgen-insensitive prostate cancer. Cancer Res.69, 151–160 (2009).
- Kerlikowske K, Molinaro AM, Gauthier ML et al. Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. J. Natl Cancer Inst.102, 627–637 (2010).
- Pavlides S, Tsirigos A, Migneco G et al. The autophagic tumor stroma model of cancer: role of oxidative stress and ketone production in fueling tumor cell metabolism. Cell Cycle9, 3485–3505 (2010).
- Witkiewicz AK, Dasgupta A, Sotgia F et al. An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers. Am. J. Pathol.174, 2023–2034 (2009).
- Sloan EK, Ciocca DR, Pouliot N et al. Stromal cell expression of caveolin-1 predicts outcome in breast cancer. Am. J. Pathol.174, 2035–2043 (2009).
- Di Vizio D, Morello M, Sotgia F, Pestell RG, Freeman MR, Lisanti MP. An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation. Cell Cycle8, 2420–2424 (2009).
- Marumoto T, Zhang D, Saya H. Aurora-A – a guardian of poles. Nat. Rev. Cancer5, 42–50 (2005).
- Hoque A, Carter J, Xia W et al. Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breast. Cancer Epidemiol. Biomarkers Prev.12, 1518–1522 (2003).
- Zhou H, Kuang J, Zhong L et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat. Genet.20, 189–193 (1998).
- Tomlins SA, Rhodes DR, Perner S et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science310, 644–648 (2005).